Cambridge, Massachusetts-based X4 Pharmaceuticals has appointed John Celebi as its new chief operating officer.
Celebi brings over 20 years of biotech industry experience to the role, and will take on responsibility for X4’s business development, operations and corporate development.
Most recently, he served as chief business officer of Igenica Biotherapeutics, and has previously held senior positions at Agilent Technologies, ArQule, Biogen and Cyclis Pharmaceuticals.
Paula Regan, president and chief executive of X4, said: “John has a tremendous knowledge-base for evolving an emerging biotech company across the range of critical business capabilities.
“His experience will be essential to achieving X4’s mission of developing novel CXCR4 therapies that have the potential to make a significant impact in the cancer treatment landscape, and we look forward to tapping into his business-building expertise as we continue to pursue the development of X4P-001 and our portfolio of CXCR4 inhibitors.”